Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 4, 2012, Pages 667-672

  Guan, Shuang ^a   Xiong, Ying ^a   Song, Bocui ^a   Song, Yu ^a   Wang, Dacheng ^a   Chu, Xiao ^a   Chen, Na ^a   Huo, Meixia ^a   Deng, Xuming ^a   Lu, Jing ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

ALI; LPS; Protective; Salidroside

Indexed keywords

DEXAMETHASONE; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; SALIDROSIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRY WEIGHT; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG PARENCHYMA; LUNG WEIGHT; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RHODIOLA; SINGLE DRUG DOSE;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; GLUCOSIDES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PHENOLS; RHODIOLA;

MUS; RHODIOLA ROSEA;

EID: 84863786261     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.650175     Document Type: Article

References (28)

1. Kelly, G.S. Rhodiola rosea: A possible plant adaptogen. Altern Med Rev 2001, 6, 293-302.
2. Huang, S.C., Lee, F.T., Kuo, T.Y., Yang, J.H., Chien, C.T. Attenuation of long-term Rhodiola rosea supplementation on exhaustive swimming-evoked oxidative stress in the rat. Chin J Physiol 2009, 52, 316-324.
3. Iaremii, I.N., Grigor'eva, N.F. Hepatoprotective properties of liquid extract of Rhodiola rosea. Eksp Klin Farmakol 2002, 65, 57-59.
4. Ming, D.S., Hillhouse, B.J., Guns, E.S., Eberding, A., Xie, S., Vimalanathan, S., Towers, G.H. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 2005, 19, 740-743.
5. Mattioli, L., Perfumi, M. Rhodiola rosea L. extract reduces stressand CRF-induced anorexia in rats. J Psychopharmacol (Oxford) 2007, 21, 742-750.
6. Perfumi, M., Mattioli, L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 2007, 21, 37-43.
7. Li, H.B., Chen, F. Preparative isolation and purification of salidroside from the Chinese medicinal plant Rhodiola sachalinensis by highspeed counter-current chromatography. J Chromatogr A 2001, 932, 91-95.
8. Wang, J.M., Shan, J.P., Wang, S.Q. Progress of research study on pharmacological action of Rhodiola rosea. J ACMP, 2003, 31, 57-59.
9. Kucinskaite, A., Briedis, V., Savickas, A. Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine. Medicina (Kaunas) 2004, 40, 614-619.
10. Haibo Wang, Yuanyuan Ding. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackie virus B3. J Phytomedicine, 2009, 16, 146-155.
11. Wu, Y.L., Lian, L.H., Jiang, Y.Z., Nan, J.X. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Pharm Pharmacol 2009, 61, 1375-1382.
12. Yin, D., Yao, W., Chen, S., Hu, R., Gao, X. Salidroside, the main active compound of Rhodiola plants, inhibits high glucose-induced mesangial cell proliferation. Planta Med 2009, 75, 1191-1195.
13. Gen-xiang Mao et al. Protective effect against aging in a mouse model induced by d-galactose. Biomed Environ Sci, 2010, 23, 161-166.
14. Shuang guan et al. Adjuvant effects of salidroside from Rhodiola rosea L. on the immune responses to ovalbumin in mice. Immunopharmacol Immunotoxicol, 2011, 33, 738-743.
15. Jian-Rong Shi et al. Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice. Int Immunopharmacol, 2010, 10, 1235-1241.
16. Lee, W.L., Downey, G.P. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001, 7, 1-7.
17. Rochelle, L.G., Fischer, B.M., Adler, K.B. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 1998, 24, 863-868.
18. MacCallum, N.S., Evans, T.W. Epidemiology of acute lung injury. Curr Opin Crit Care 2005, 11, 43-49.
19. Jain, R., DalNogare, A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc 2006, 81, 205-212.
20. Zhibao Chen et al. Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice. Inflammation 2010, 33, 306-14.
21. Rainsford, K.D. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007, 42, 3-27.
22. Brigham, K.L., Meyrick, B. Endotoxin and lung injury. Am Rev Respir Dis 1986, 133, 913-927.
23. Worthen, G.S., Haslett, C., Rees, A.J., Gumbay, R.S., Henson, J.E., Henson, P.M. Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 1987, 136, 19-28.
24. Beck, B.D., Brain, J.D., Bohannon, D.E. An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol 1982, 66, 9-29.
25. Pei-Yi Chu, Se-Ping Chien, Dur-Zong Hsu, Ming-Yie Liu. Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats. Food Chem Toxicol, 2010, 48, 1821-1826.
26. Sone, Y., Serikov, V.B., Staub, N.C., Sr. Intravascular macrophage depletion attenuates endotoxin lung injury in anesthetized sheep. J Appl Physiol 1999, 87, 1354-1359.
27. Minamino, T., Komuro, I. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. J Clin Invest 2006, 116, 2316-2319.
28. Jung, C.H., Kim, J.H., Hong, M.H., Seog, H.M., Oh, S.H., Lee, P.J., Kim, G.J., Kim, H.M., Um, J.Y., Ko, S.G. Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-êB and JNK pathway in lipopolysaccharideinduced RAW 264.7 macrophages. J Ethnopharmacol 2007, 110, 490-497.